Abundance: Results For Full Year Ended 31 December 2019.

25 Feb 2020 18:04

For FY2019, the Group recorded US$360.5 million of revenue, mainly arising from the chemical trading business undertaken by our wholly-owned subsidiary, OrientSalt Chemicals Pte. Ltd., and its subsidiaries. The Group recorded loss before interest, taxes, depreciation and amortisation for FY2019 of US$0.7 million. There was a loss attributable to the shareholders of US$2.5 million after deducting costs incurred at the Company level...

Attachments: